Audio long read: Conquering Alzheimer’s — a look at the therapies of the future
Nature Podcast
00:00
The Future of Alzheimer's Treatment
L'acannamab, marketed in the United States as l'acambi, makes for a tough treatment regime. It has to be infused through a vein by a nursing professional. Because it can cause potentially life-threatening brain swelling and bleeds, people taking it have to be monitored regularly. A similar antibody, Adju-cannamab was approved by the US Food and Drug Administration in 2021,. but the decision generated controversy because the drug's clinical trial had not shown an ambiguous benefit.
Transcript
Play full episode
